Literature DB >> 17970799

A longitudinal study over 5 to 10 years of clinical outcomes in women with idiopathic detrusor overactivity.

A R Morris1, J I Westbrook, K H Moore.   

Abstract

OBJECTIVE: To evaluate the long-term clinical outcome in women with idiopathic detrusor overactivity (IDO) and to identify significant prognostic factors.
DESIGN: Longitudinal study incorporating retrospective case note review and a postal questionnaire.
SETTING: Tertiary referral urogynaecology clinic in Australia. POPULATION: Women with a sole urodynamic diagnosis of IDO.
METHODS: Audit of urodynamic records and case notes. Postal questionnaire incorporating validated disease-specific quality-of-life (QoL) instruments. MAIN OUTCOME MEASURE: Subjective assessment of overall improvement on a 4-point scale followed by scoring of short forms of the urogenital distress inventory and incontinence impact questionnaire.
RESULTS: One hundred and thirty two women were identified following examination of 1975 consecutive records with 76 (67%) returning questionnaires. Median follow up was 8 years (6-9), and the duration of symptoms was 13 years (9-18). Improvement was achieved in 25 (35%) women. Disease symptoms fluctuated in severity and QoL were worse in nonresponders to therapy (P < 0.0001). Urge incontinence at presentation was associated with treatment failure (P = 0.001) as was nocturia (P = 0.04), but urodynamic variables were not associated with outcome. Only 3 of 46 (6.5%) women not responding to therapy thought that their symptoms would improve with time.
CONCLUSIONS: IDO seldom resolves and fluctuates in severity. Individual response is unpredictable, although the presence of urge incontinence is associated with a significantly worse prognosis.

Entities:  

Mesh:

Year:  2007        PMID: 17970799     DOI: 10.1111/j.1471-0528.2007.01527.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  5 in total

Review 1.  Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.

Authors:  Thomas J Hannan; Makrina Totsika; Kylie J Mansfield; Kate H Moore; Mark A Schembri; Scott J Hultgren
Journal:  FEMS Microbiol Rev       Date:  2012-05       Impact factor: 16.408

Review 2.  Considerations for the management of urgency symptoms in patients with overactive bladder syndrome.

Authors:  Linda D Cardozo; Philip E V A Van Kerrebroeck; David R Staskin
Journal:  World J Urol       Date:  2009-12       Impact factor: 4.226

Review 3.  Urinary Tract Infection in Overactive Bladder: An Update on Pathophysiological Mechanisms.

Authors:  Kylie J Mansfield; Zhuoran Chen; Kate H Moore; Luke Grundy
Journal:  Front Physiol       Date:  2022-07-04       Impact factor: 4.755

4.  Virulence Mechanisms of Common Uropathogens and Their Intracellular Localisation within Urothelial Cells.

Authors:  Samantha Ognenovska; Chinmoy Mukerjee; Martina Sanderson-Smith; Kate H Moore; Kylie J Mansfield
Journal:  Pathogens       Date:  2022-08-17

Review 5.  Role of fesoterodine in the treatment of overactive bladder.

Authors:  Kylie J Mansfield
Journal:  Open Access J Urol       Date:  2009-12-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.